[Breaking] 식약처 Advisory Panel: "Jongkundang COVID-19 Treatment Efficacy Not Proven"
![[Breaking] 식약처 Advisory Panel: "Jongkundang COVID-19 Treatment Efficacy Not Proven"](http://www.asiae.co.kr/news/img_view.htm?img=2020120409454047289_1607042740.png)
[Asia Economy Reporter Lee Seon-ae]
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- NVIDIA Reports $81.6 Billion in Q1 Revenue, Sets Record for 12 Consecutive Quarters (Comprehensive)
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
